Pesquisas alternativas:
doses develop » loss develop (Expandir a Pesquisa), models develop (Expandir a Pesquisa), locus develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
dna develop » 133a develop (Expandir a Pesquisa), cd38 develop (Expandir a Pesquisa), esau develop (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
a develop » _ develop (Expandir a Pesquisa), 3 develop (Expandir a Pesquisa), a developed (Expandir a Pesquisa)
doses develop » loss develop (Expandir a Pesquisa), models develop (Expandir a Pesquisa), locus develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
dna develop » 133a develop (Expandir a Pesquisa), cd38 develop (Expandir a Pesquisa), esau develop (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
a develop » _ develop (Expandir a Pesquisa), 3 develop (Expandir a Pesquisa), a developed (Expandir a Pesquisa)
81
Por V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova
Publicado em 2021-08-01
Assuntos:
“...antiepileptic drugs...”Publicado em 2021-08-01
Obter o texto integral
Artigo
82
“... and their application in a pharmacokinetic study. The pharmacokinetic study involved a single oral dose of the drug...”
Obter o texto integral
Obter o texto integral
Artigo
83
Por Vladimir T. Ivashkin, Andrey Yu. Baranovsky, Karina L. Raikhelson, Lyudmila K. Palgova, Marina V. Maevskaya, Elina A. Kondrashina, Natalya V. Marchenko, Tatyana P. Nekrasova, Igor G. Nikitin
Publicado em 2019-03-01
Assuntos:
“...drug-induced liver injuries...”Publicado em 2019-03-01
Obter o texto integral
Artigo
84
“... in the development of drugs based on the active pharmaceutical ingredient with a bitter taste, and high-dose [12, 13...”
Obter o texto integral
Obter o texto integral
Artigo
85
Por Demonceau, Jenny, Ruppar, Todd, Kristanto, Paulus, Hughes, Dyfrig A., Fargher, Emily, Kardas, Przemyslaw, De Geest, Sabina, Dobbels, Fabienne, Lewek, Pawel, Urquhart, John, Vrijens, Bernard
Publicado em 2013
“... of strategies and components thereof that improve implementation of the prescribed drug dosing regimen...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
86
“...AG1343, a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) protease (Ki = 2 nM...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
87
“... range of dosages (low, standard, or high) and for different drug types. Fetuses exposed to standard...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
88
Por Mearns, Elizabeth S., Sobieraj, Diana M., White, C. Michael, Saulsberry, Whitney J., Kohn, Christine G., Doleh, Yunes, Zaccaro, Eric, Coleman, Craig I.
Publicado no PLoS One (2015)
“...INTRODUCTION: When first line therapy with metformin is insufficient for patients with type 2...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
89
Por Wen-Jun Yu, Dong-Xu Huang, Shuang Liu, Ying-Li Sha, Feng-hui Gao, Hong Liu
Publicado em 2020-09-01
“... types of cancer and autoimmune diseases. The optimal dose of MTX is known to inhibit...”Publicado em 2020-09-01
Obter o texto integral
Artigo
90
Por Berg, Alexander K., Buckner, Jan C., Galanis, Evanthia, Jaeckle, Kurt A., Ames, Matthew M., Reid, Joel M.
Publicado no J Clin Pharmacol (2015)
“... suggests that a 1.7 fold increase in irinotecan dose may compensate for decreases in SN-38 exposure...”Publicado no J Clin Pharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
91
Por Eijkelkamp, Niels, Steen-Louws, Cristine, Hartgring, Sarita A. Y., Willemen, Hanneke L. D. M., Prado, Judith, Lafeber, Floris P. J. G., Heijnen, Cobi J., Hack, C. E., van Roon, Joel A. G., Kavelaars, Annemieke
Publicado no J Neurosci (2016)
“.... In search of a novel drug to treat chronic pain, we developed a fusion protein consisting of two prototypic...”Publicado no J Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
92
Por Patick, A K, Rose, R, Greytok, J, Bechtold, C M, Hermsmeier, M A, Chen, P T, Barrish, J C, Zahler, R, Colonno, R J, Lin, P F
Publicado em 1995
“...% effective dose emerged. This HIV variant displays low-level cross-resistance to the C2 symmetric inhibitor A...”Publicado em 1995
Obter o texto integral
Obter o texto integral
Artigo
93
Por Seng Manivong, Araceli Garcia Ac, Shunmoogum A. Patten, Julio C. Fernandes, Mohamed Benderdour, Xavier Banquy, Florina Moldovan, Valérie Gaëlle Roullin
Publicado em 2022-04-01
“...One important challenge in treating avascular-degraded cartilage is the development of new drugs...”Publicado em 2022-04-01
Obter o texto integral
Artigo
94
“... was assessed in suckling mice infected with coxsackievirus A-9 or echovirus type 9 (Barty) 2.5 days prior...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
95
Por Kamila Wala, Wojciech Szlasa, Natalia Sauer, Paulina Kasperkiewicz-Wasilewska, Anna Szewczyk, Jolanta Saczko, Nina Rembiałkowska, Julita Kulbacka, Dagmara Baczyńska
Publicado em 2022-04-01
Assuntos:
“...cytostatic drug...”Publicado em 2022-04-01
Obter o texto integral
Artigo
96
Por Carr, John A., Parashar, Archana, Gibson, Richard, Robertson, Alan P., Martin, Richard J., Pandey, Santosh
Publicado em 2011
“...This paper describes a new microfluidic platform for screening drugs and their dose response...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
97
“... doses of cycloheximide or emetine. We have identified and characterized a mutant strain...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
98
Por V. A. Karlov, O. V. Belyaev, P. N. Vlasov, I. A. Zhidkova, I. V. Volkov, D. V. Dmitrenko, A. Yu. Karas, T. V. Kazennykh, O. I. Miguskina, A. V. Moskvicheva, E. N. Paramonova, I. V. Ponomareva, A. V. Chervyakov
Publicado em 2016-07-01
Assuntos:
“...drug-resistant focal/partial epilepsy...”Publicado em 2016-07-01
Obter o texto integral
Artigo
99
Por Javier J.L. Rico, Vanessa M. Castilho, Sílvio Morato, Manoel Jorge Nobre
Publicado no Psychology & Neuroscience (2009)
Assuntos:
“...Drug abuse...”Publicado no Psychology & Neuroscience (2009)
Obter o texto integral
Artigo
100
Por Kavanagh, David, McGlasson, Sarah, Jury, Alexa, Williams, Jac, Scolding, Neil, Bellamy, Chris, Gunther, Claudia, Ritchie, Diane, Gale, Daniel P., Kanwar, Yashpal S., Challis, Rachel, Buist, Holly, Overell, James, Weller, Belinda, Flossmann, Oliver, Blunden, Mark, Meyer, Eric P., Krucker, Thomas, Evans, Stephen J. W., Campbell, Iain L., Jackson, Andrew P., Chandran, Siddharthan, Hunt, David P. J.
Publicado no Blood (2016)
“...-dependent drug-induced TMA. We then show that dose-dependent microvascular disease is seen in a transgenic...”Publicado no Blood (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo